Loading…
← CockpitCompetitor Analysis › 301122.SZ Caina Technology Co., Ltd. Class AOpen in the cockpit ↗

Caina Technology Co., Ltd. Class A301122.SZCompetitor analysis, valuation and peers

China · CNY·Health Care›Medical Specialties

Chinese medical-device company; specific product focus not independently confirmed with confidence.

Momentum leader 96
Mkt cap
$721M
US dollars, full cap
$/day
$39.2M
20-day average traded
Fwd P/E
55.4×
forward earnings
ROIC−WACC
-7.0 pp
WACC 10.0%
Hurdle
n/a
no reverse DCF
Next earnings
146 days
13 Apr 2027
Close · CNYCN¥42.48
1D-6.2%
1W-28.4%
1M-33.9%
3M+20.5%
6M+36.5%
YTD+63.0%
1Y+32.0%
ATR %11.8%
52w lowhigh40.8% off high

What Caina Technology does

Chinese medical-device company; specific product focus not independently confirmed with confidence.

Where it sits in the supply chain

  • Health Care
  • Medical devices

Moat: none

Headquarters: China · Employees: 1,057

Caina Technology at a glance

Size Caina Technology (301122.SZ) is a China Health Care company (Medical Specialties) with a market value of $721M, the 2836th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥42.48 on 18 Nov 2026.

Performance Over six months the shares gained 36.5%, against -17.5% for the median peer and -20.0% for the China market (cap-weighted) — 3rd highest of 21 in its peer set.

Growth Revenue grew 61.4% over the last twelve months (peer median +14.8%); the operating margin is 0.3% (peer median 13.7%).

Valuation It trades at 55.4× forward earnings against a peer median of 23.2× (4th most expensive of 17).

Capital Return on invested capital runs 7.0 points below its cost of capital (10.0% WACC).

Next results Next results expected around 13 Apr 2027 (exchange calendar; dates can move).

Relative performance

10015020025021 May 202621 Aug 202618 Nov 2026301122.SZ 146Peer median 84
Six months, rebased to 100: Caina Technology against the median of its 20 peers (local-currency closes).

Caina Technology financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥551MCN¥355MCN¥387MCN¥410MCN¥463M
Revenue growth—-8%-6%-12%—
Gross profitCN¥174MCN¥71.9MCN¥136MCN¥154MCN¥183M
EBITDAn/aCN¥52.5MCN¥64.3MCN¥123MCN¥162M
Net incomeCN¥13.5MCN¥5.62MCN¥53.1MCN¥113MCN¥162M
Free cash flow-CN¥66.8M-CN¥64.5MCN¥22.0M-CN¥91.7M-CN¥26.0M
Capital expenditureCN¥76.4MCN¥92.7MCN¥102MCN¥198MCN¥165M
Total debtCN¥167MCN¥31.4MCN¥35.4MCN¥429,469CN¥455,912

Quarterly statements and history in the cockpit →

Caina Technology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%3006226881796884103013676008557575INMD1501603108300453301234002950688085688389688108491000DCTH2190301122.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Caina Technology is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%0×200×400×3006226881796884103013677575603108688085688389688108300463DCTH002876301122.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Caina Technology is the large dot.

Caina Technology competitors and peer comparison

How Caina Technology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Caina Technology against its 20 peers (data as of 18 Nov 2026)
Measure301122.SZPeer medianRank in peer set
1-month return-33.9%-8.5%lowest of 21
6-month return+36.5%-17.5%3rd highest of 21
Distance from 52-week high-40.8%-38.3%10th lowest of 21
Revenue growth (TTM)+61.4%+14.8%2nd highest of 21
Operating margin0.3%13.7%5th lowest of 21
Forward P/E55.4×23.2×4th most expensive of 17
ROIC minus cost of capital-7.0 pp+3.5 pp3rd lowest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Caina Technology 301122.SZChina$721M+36%+61%0%55.4×n/an/a
Doctorglasses Chain 300622.SZChina$710M-22%+6%14%22.8×-3.4%+15.7%
Shanghai Aladdin Biochemical Technology 688179.SSChina$736M-37%+39%24%27.4×17.1%+24.2%
SWS Hemodialysis Care 688410.SSChina$706M-11%+31%19%23.5×16.2%+25.9%
BMC Medical 301367.SZChina$737M-17%+37%17%18.7×-1.5%+15.6%
Beijing Aerospace Changfeng 600855.SSChina$738M-44%-10%-19%n/an/an/a
Japan Lifeline 7575.TJapan$703M+34%+6%19%14.5×-9.5%+2.9%
InMode INMDUnited States$741M-8%+2%18%9.8×-10.8%+12.4%
Shanghai INT Medical Instruments 1501.HKHong Kong$700M-25%+35%21%15.9×-3.3%+23.5%
Shanghai Runda Medical Technology 603108.SSChina$744M-36%-12%-2%20.5×20.3%-0.2%
Jiang Xi Sanxin Medtec 300453.SZChina$744M-3%+12%18%16.2×-1.9%+11.8%
Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZChina$697M+148%-14%3%n/a31.8%-0.6%
Allmed Medical Products 002950.SZChina$747M-32%+14%8%n/an/an/a
Shanghai Sanyou Medical 688085.SSChina$692M-23%+15%4%50.0×29.0%+6.8%
Shenzhen Lifotronic Technology 688389.SSChina$692M-14%+14%13%29.9×11.6%+13.3%
Sino Medical Sciences Technology 688108.SSChina$753M-41%+22%19%60.0×27.9%+9.9%
Livsmed 491000.KSSouth Korea$687M-47%+89%-77%n/an/an/a
Maccura Biotechnology 300463.SZChina$756M-18%-1%-4%421.0×7.9%-10.2%
Delcath Systems DCTHUnited States$685M+75%+38%5%358.9×33.4%+120.2%
Shenzhen Sunnypol Optoelectornics 002876.SZChina$680M-9%+29%5%39.0×10.1%+14.2%
Zylox-Tonbridge Medical Technology 2190.HKHong Kong$768M-16%+39%25%14.4×3.8%+105.8%

Questions

Which companies are Caina Technology's closest peers?
The cockpit's peer set: Doctorglasses Chain (300622.SZ), Shanghai Aladdin Biochemical Technology (688179.SS), SWS Hemodialysis Care (688410.SS), BMC Medical (301367.SZ), Beijing Aerospace Changfeng (600855.SS), Japan Lifeline (7575.T), InMode (INMD), Shanghai INT Medical Instruments (1501.HK).
Is Caina Technology expensive compared with its peers?
On forward p/e it trades at 55.4× against a peer median of 23.2×, 4th most expensive of 17 in its peer set.
How has Caina Technology stock performed?
Over six months to 18 Nov 2026 the shares returned +36.5% against -17.5% for the median peer; over one year +32.0%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.